Research on Alzheimer’s and Parkinson’s Less Than 2 percent of NIH budget
Research on Alzheimer’s and Parkinson’s diseases consumes less than 2% of the entire National Institutes of Health (NIH) budget. Despite the world-wide market for medications that prevent or halt both Alzheimer’s and Parkinson’s diseases, no such drugs exist. In large part, this is traceable to the diminutive spending on research on these and other neurodegenerative diseases. Ironically, as dementia in older people has grown more common, it’s come to be thought of as an inevitable consequence of aging, even though the majority of elderly people aged 80 to 100 have well-preserved memories and intellect.